EPHA4 and Alzheimer disease: In the context of AD, genetic reduction or pharmacological blockage of EphA4 rescues Aβ-induced dendritic spine loss and long-term potentiation (LTP) deficits in cultured hippocampal slices and primary hippocampal cultures [21, 22].